Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases.
Wang Y, Fung NSK, Lam WC, Lo ACY. Wang Y, et al. Antioxidants (Basel). 2022 Jun 29;11(7):1304. doi: 10.3390/antiox11071304. Antioxidants (Basel). 2022. PMID: 35883796 Free PMC article. Review.
Recent advances in the research of the mammalian target of the rapamycin (mTOR) signalling pathway demonstrated that mTOR is a robust therapeutic target for ocular degenerative diseases, including age-related macular degeneration (AMD), diabetic retinopathy (DR), and glauc …
Recent advances in the research of the mammalian target of the rapamycin (mTOR) signalling pathway demonstrated that mTOR is a robust …
Cell Ferroptosis: New Mechanism and New Hope for Retinitis Pigmentosa.
Yang M, So KF, Lam WC, Lo ACY. Yang M, et al. Cells. 2021 Aug 21;10(8):2153. doi: 10.3390/cells10082153. Cells. 2021. PMID: 34440922 Free PMC article. Review.
We propose that ferroptotic cell death not only opens up a new research area in RP, but may also serve as a novel therapeutic target for RP....
We propose that ferroptotic cell death not only opens up a new research area in RP, but may also serve as a novel therapeutic target …